| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8922499 | Clinical and Translational Radiation Oncology | 2017 | 6 Pages |
Abstract
Pre-treatment and on-treatment anemia were significant, independent predictors of worse PFS and OS. Anemia and other hematologic parameters remain prognostic markers for cervical cancer patients. Improvement in PFS and OS was seen in patients with normalization of hemoglobin.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Theodora A. Koulis, Elizabeth N. Kornaga, Robyn Banerjee, Tien Phan, Prafull Ghatage, Anthony M. Magliocco, Susan P. Lees-Miller, Corinne M. Doll,